- Login
- Manage Portfolio
- Post a StockTalk
- Write an Instablog
- Get Daily Email Alert
-
Seeking Alpha
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: | |
Articles on Cardiome Pharma Corp. (CRME)
by latest | most commented
-
Cardiome May See More Upside When IV Formulation Is Clarified - RBC
-
How Will Cardiome, Merck, Eli Lilly, and Par Pharma's Phase 3 Trials Perform?
-
Merck / Cardiome: Big Pharma Meets Baby Biotech
-
Biopharma: Instead of M&A, Think P&A
-
Hedge Fund Tracking: Farallon Capital Management (Thomas Steyer), Q3 2008
-
Potential Short Trades on Pending FDA Decisions
-
Monday Options Outlook: AMZN, MCD, EL, CRME, VRX, CCK, CNO
-
FDA Calendar: Cardiome, Momenta, Discovery Labs, Introgen
-
Cardiome Pharma: More Encouraging Trial Results
-
Six Canadian Life Sciences Stocks
-
Earnings Season: Four Hits and Misses
-
Under The Radar News - Thursday
-
Cardiome Pharma: Stock Up 30% on Positive Clinical Trials
-
Monday's Options Report: LEH, VIX, MF, C, CRME
-
Wednesday's Options Report: XLF, Bank of America, EMC, SGP, Bon Ton
-
NovaGold, Teck Cominco and Cardiome Pharma Stock Drop
-
Cardiome, Amylin: Good Science Makes for Great Biotech Values in Market Downturn
-
Earnings Schedule and Estimates for Monday, August 14, 2006